Skip to main content
. 2021 Jan 20;52(1):117–123. [Article in Chinese] doi: 10.12182/20210160601

表 4. Likely pathogenic CNVs in 11 fetuses.

11例可能致病性CNVs结果

No. Age/
yr.
a-CGH results Known syndromes Sizes of
CNVs/kb
Copy
number
OMIM
gene
Inherited or
de novo
 TAR: Thrombocytopenia-absent radius syndrome; AZFb: Azoospermia factor area B; RBM8A: RNA-binding motif protein 8A; CNTN4: Contactin 4; YTHDC1: YTH domain-containing protein 1; CRKL: V-CRK avian sarcoma virus ct10 oncogene homolog-like. CNVs,OMIM,MYH11, CMT1A, PMP22: Notes same as the table 3.
25 36 arr[GRCh37] 1q21.1
 (145388977_145746492)x1
1q21.1 recurrent (TAR syndrome)
 region (BP2-BP3, proximal) (includes RBM8A)
358 Loss RBM8A de novo
26 36 arr[GRCh37] 3p26.3p26.2
 (101072_3576969)x1
/ 3 476 Loss CNTN4/CNTN6 de novo
27 37 arr[GRCh37] 4q13.2q21.23
 (68632189_85505332)x1
/ 16 873 Loss YTHDC1 de novo
28 37 arr[GRCh37] 16p13.11
 (15125829_16282387)x3
16p13.11 recurrent microduplication
 (neurocognitive disorder susceptibility locus) (77.1%)
1 157 Gain MYH11 de novo
29 40 arr[GRCh37] 16p13.11p12.3
 (15512480_18128488)x3
16p13.11 recurrent microduplication
 (neurocognitive disorder susceptibility locus) (64.9%)
2 616 Gain MYH11 de novo
30 36 arr[GRCh37] 17p12
 (13478126_14621537)x3
Charcot-Marie-Tooth syndrome type 1A
 (CMT1A) (38.1%)
1 143 Gain PMP22 de novo
31 35 arr[GRCh37] 22q11.21
 (20734765_21417548)x3
22q11.2 recurrent region
 (central, B/C-D) (includes CRKL)
683 Gain CRKL de novo
32 37 arr[GRCh37] 22q11.21
 (20734765_21417548)x3
22q11.2 recurrent region
 (central, B/C-D) (includes CRKL)
683 Gain CRKL de novo
33 42 arr[GRCh37] 22q11.21
 (20734765_21417548)x3
22q11.2 recurrent region
 (central, B/C-D) (includes CRKL)
683 Gain CRKL de novo
34 35 arr[GRCh37] Xp21.3p21.1
 (26014588_34408233)x2
/ 8 394 Gain / de novo
35 34 arr[GRCh37] Yq11.222q11.223
 (20812161_24396347)x0
AZFb (60.3%) 3 584 Loss / de novo